Koch C - Search Results

1

Use of antibiotics in cystic fibrosis. The Danish approach.

Jensen T, Pedersen SS, Høiby N, Koch C, Flensborg EW. Jensen T, et al. Among authors: koch c. Antibiot Chemother (1971). 1989;42:237-46. Antibiot Chemother (1971). 1989. PMID: 2688545 Review. No abstract available.

2

Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient.

Main KM, Skov M, Sillesen IB, Dige-Petersen H, Müller J, Koch C, Lanng S. Main KM, et al. Among authors: koch c. Acta Paediatr. 2002;91(9):1008-11. doi: 10.1080/080352502760272759. Acta Paediatr. 2002. PMID: 12412882

3

[Glucose tolerance in patients with cystic fibrosis].

Thorsteinsson SL, Hansen A, Thorsteinsson B, Nerup J, Koch C. Thorsteinsson SL, et al. Among authors: koch c. Ugeskr Laeger. 1996 Oct 28;158(44):6269-73. Ugeskr Laeger. 1996. PMID: 8966811 Danish.

4

[Reduced concentration of insulin-like growth factor I in patients with cystic fibrosis].

Laursen EM, Juul A, Thorsteinsson SL, Høiby N, Koch C, Müller JR, Skakkebaek NE. Laursen EM, et al. Among authors: koch c. Ugeskr Laeger. 1996 Sep 16;158(38):5300-2. Ugeskr Laeger. 1996. PMID: 8966779 Danish.

5

Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis.

Kronborg G, Pressler T, Fomsgaard A, Koch C, Høiby N. Kronborg G, et al. Among authors: koch c. Infection. 1993 Sep-Oct;21(5):297-302. doi: 10.1007/BF01712448. Infection. 1993. PMID: 8300245

6

Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.

Hartling SG, Garne S, Binder C, Heilmann C, Petersen W, Petersen KE, Koch C. Hartling SG, et al. Among authors: koch c. Diabetes Res. 1988 Apr;7(4):165-9. Diabetes Res. 1988. PMID: 3042255

7

Serum antibodies to Aspergillus fumigatus catalase in patients with cystic fibrosis.

Schønheyder H, Jensen T, Laessøe IH, Høiby N, Koch C. Schønheyder H, et al. Among authors: koch c. Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):40-4. doi: 10.1007/BF01962169. Eur J Clin Microbiol Infect Dis. 1988. PMID: 3132374

8

Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis.

Pressler T, Jensen ET, Espersen F, Pedersen SS, Høiby N, Koch C. Pressler T, et al. Among authors: koch c. Pediatr Pulmonol. 1994 Jan;17(1):31-40. doi: 10.1002/ppul.1950170107. Pediatr Pulmonol. 1994. PMID: 8108174

9

[Prevention of cystic fibrosis?].

Koch C. Koch C. Ugeskr Laeger. 1996 Aug 12;158(33):4622. Ugeskr Laeger. 1996. PMID: 8760516 Danish. No abstract available.

10

Glucose tolerance in patients with cystic fibrosis: five year prospective study.

Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Lanng S, et al. Among authors: koch c. BMJ. 1995 Sep 9;311(7006):655-9. doi: 10.1136/bmj.311.7006.655. BMJ. 1995. PMID: 7549632 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results